CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
APAC
CANADA

About Us

Conference

Partner With Us
  • Europe
    • US
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Biotech
    Cancer Immunotherapy
    Cell and Gene Therapy Companies
    Clinical Trial Management
    Drug Discovery and Development
    Genomics
    Therapeutics
    Women's Health
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    CDMO
    Clinical Laboratory Services
    CRO
    Microgravity R&D
    Supplements
  • Business Services
    Clinical Research Training
    Life Science Consulting
    Life Science Logistics
    Life Science Marketing
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading
Top Therapeutics Companies in Europe Cancer Immunotherapies Company Of The Year In Europe - 2025 Top Therapeutics Companies in Europe - 2024 Top Therapeutics Companies in Europe - 2023

Life Sciences Review

Therapeutics

Unlocking the Potential: Swiss Pension Funds' Untapped Opportunity in Venture Capital

Unlocking the Potential: Swiss Pension Funds' Untapped Opportunity in Venture Capital

Clinical-stage Pharmaceutical And Therapeutic Development Solutions In Europe

When Food Intake Becomes Part of the Treatment

Prof. Dr Ard Peeters

Founder, CEO and CSO

Orexa

Featured Issue
#

The Revolutionary Power of Cell and Gene Therapies

Stefano Baila, Managing Director support Biologics (Cell and Gene) Eurofins
#

New Product Liability Directive in Europe: Implications for the Pharmaceutical Industry

Xavier Salas, Head of Legal, Compliance and GRC Neuraxpharm
#

The serialisation system - Atessia, Life Science Advisors

Amélie NICOLAS-VERLEY, Regulatory and Pharmaceutical Affairs Advisor
#

Cancer Immunotherapies

Democratizing CAR-T Cell Therapy

Dr. Ulf Grawunder, CEO T-CURX
Evolution of the Contract Development and Manufacturing Industry in the Last Years

Evolution of the Contract Development and Manufacturing Industry in the Last Years

Massimiliano Brescia, Senior Global Director - Contract Manufacturing - OSD, API & Fermentation

AbbVie

Elevating CDMO Performance with Strategic Alignment

Elevating CDMO Performance with Strategic Alignment

Stephen Sheehan, Director of External Development and Manufacturing

Alkermes [NASDAQ: ALKS]

#

Enabling Next-Generation Tissue Regeneration

Dr. An Van Den Bulcke, Chief Executive Officer a.i. and Co-Founder

4Tissue

News

Inventus welcomes senior figure from Google as a board adviser

Advancing Nutritional Recovery through Local Therapy

What Medical Device Sponsors Need From European CROs

Clinical-Stage Drug Developers Face Greater Pressure Around Development Planning in Europe

Loading...
#

Transforming ADC Development to Boost Innovation in Oncology

Jan Ericsson, Owner and Executive Director

#

Microbiome-derived Therapeutics for a Healthier Gut

Dr. Juan Basterra, CEO and Co-Founder

#

Pioneering Breakthrough Remedies for Terminal Health Conditions

Dr. Paul Reid, CEO and Co-Founder

#

Driving Innovations in Therapeutics Driven by Robust R&D

Giammario Piras, Senior VP, Diadema Farmaceutici

Bridging Gaps in Patient Care with Innovative Therapeutic Solutions

Bridging Gaps in Patient Care with Innovative Therapeutic Solutions

Riccardo Carbucicchio, CEO

Revolutionising Cancer Immunotherapy By Reawakening The Immune System

Cancer Immunotherapy

Revolutionising Cancer Immunotherapy By Reawakening The Immune System

Matthew Halpert, Founder and CEO, Immunocine

#

Trends Shaping The Future Of Ambulatory Rehabilitation

Michael Schmidt, Director of Ambulatory Rehabilitation, Duke University Health System

News

Advancing Nutritional Recovery through Local Therapy

Clinical-Stage Drug Developers Face Greater Pressure Around Development Planning in Europe

European Pharma Buyers Are Looking More Closely at What Development Services Actually Cover

Handoffs Could Become a Weak Point as Clinical Development Programs Expand

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://therapeutics-europe.lifesciencesreview.com